MedTrace Logo

Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care

NCT05580549 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2022-10-20

No results posted yet for this study

Summary

The goal of this observational cross-sectional study is to map the prevalence of hazardous alcohol use in 270 adult patients with hypertension in Primary Health Care (PHC). The main question it aims to answer is: What is the prevalence of hazardous alcohol use in a population with hypertension in primary care detected with PEth and AUDIT, analysed in relation to patients with controlled, uncontrolled and treatment resistant hypertension? Participants will, in conjunction with annual control of hypertension with a General Practitioner (GP) at their Primary Health Care Centre (PHCC), visit a study nurse. The study nurse will collect following data: • Physical measurements• Lifestyle habits• Quality of life and demographic data • Drugs for hypertension and comorbidity • Laboratory tests including Phosphatidylethanol (PEth).

Conditions

Interventions

DIAGNOSTIC_TEST

Alcohol biomarker Phosphatidylethanol (PEth)

The prevalence of hazardous alcohol use will be mapped through the biomarker PEth and the questionnaire AUDIT.

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Forte

    collaborator INDUSTRY

  • Sophiahemmet University

    collaborator OTHER

  • Region Stockholm

    lead OTHER_GOV

Principal Investigators

  • Lena Lund, PhD · Region Stockholm

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05580549 on ClinicalTrials.gov